Fig. 2From: Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile testKaplan-Meier recurrence-free survival curves for class 1 (blue) and class 2 (red) subjects in the prospective registry cohort (solid lines; n = 322) and collective retrospective studies (dashed lines; n = 782)Back to article page